Group One Trading, L.P. Onconova Therapeutics, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.69 - $1.42 $1,593 - $3,280	-2,310 Reduced 58.88%	1,613 $1,000
Q4 2022 Feb 09, 2023	BUY	$0.63 - $0.97 $126 - $194	200 Added 5.37%	3,923 $2,000
Q1 2022 May 12, 2022	SELL	$1.46 - $2.82 $146 - $282	-100 Reduced 2.62%	3,723 $7,000
Q4 2021 Feb 11, 2022	SELL	$2.49 - $3.73 $5,657 - $8,474	-2,272 Reduced 37.28%	3,823 $10,000
Q3 2021 Nov 12, 2021	BUY	$3.81 - $6.76 $23,221 - $41,202	6,095 New	6,095 $23,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.